Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Biogen, Inc. (NQ: BIIB )

269.87 USD +6.30 (+2.39%)
Streaming Delayed Price Updated: 2:11 PM EST, Mar 5, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Stories about Biogen, Inc.

< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Biogen To Build New Gene Therapy Facility With $200M Investment
Biogen Inc(NASDAQ:BIIB)plans to build a new gene therapy manufacturing facilityat its Research Triangle Park ... 
Tags Health Care News Benzinga
From Benzinga
These Are John Buckingham’s Stock Picks For 2021
The economy remains in distress, although there are signs of recovery underway. 
Tags Market News Stocks / Equities
From Blogs - TalkMarkets
Noteworthy Wednesday Option Activity: WMT, DRI, BIIB
Among the underlying components of the S&P 500 index, we saw noteworthy options trading volume today in Walmart Inc (WMT), where a total of 70,804 contracts have traded so far, representing... 
Tags Stocks
From Market News Video
Should Investors Be Watching These Top Health Care Stocks Right Now?
Tags Market News
From StockMarket.com
Biotech Stocks Can Provide Growth and Value in a Volatile Market
Healthcare stocks lagged in February with the rebalancing. 
Tags Healthcare Pharma/Biotech Market News
From Blogs - TalkMarkets
7 Stocks to Sell for March
<p><a rel="nofollow" href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice & Trading Tips</a></p> <p>The market is starting to get volatile again and sector rotation is... 
Tags T BSX GSK
From InvestorPlace
2 Best Pharma Stocks to Buy Right Now
These under-appreciated pharma stocks have the potential to become long-term winners. 
Tags NVS REGN ABBV
From Motley Fool
Where Will Biogen Be in 5 Years?
The biotech has a lot riding on whether the FDA approves its potential Alzheimer's treatment, aducanumab. 
Tags Market News ESALF BIIB
From Motley Fool
Should Investors Worry About Moderna's Vaccine Delays?
The short answer: No. 
Tags REGN BIIB MRNA
From Motley Fool
What Are the Long-Term Prospects for Moderna?
The biotech's messenger RNA platform is promising. But some investors could have qualms about its current valuation. 
Tags PFE MRNA Market News
From Motley Fool
Will Editas Medicine's CEO Change Help or Hurt?
Turnover at the top of a company can be troubling. But it can sometimes be a good thing. 
Tags EDIT NTLA Market News
From Motley Fool
Is Biogen Stock a Buy?
Investors have been riding a roller coaster over the past year. 
Tags Market News XLV BIIB
From Motley Fool
lululemon athletica Larger Than S&P 500 Component Biogen
In the latest look at stocks ordered by largest market capitalization, Russell 3000 component lululemon athletica inc (LULU) was identified as having a larger market cap than the smaller end of the S&P... 
Tags Stocks
From Market News Video
Here's What Caused Royalty Pharma's Mixed Results in Q4
The company's royalties revenue soared, but its earnings sank. 
Tags NVS JNJ ABBV
From Motley Fool
22 additional dividend stocks that Warren Buffett might consider buying
His Berkshire Hathaway conglomerate recently started buying shares of Verizon and Chevron --- both have attractive dividend yields well-supported by expected cash flow. 
Tags KHC AMZN PFE
From MarketWatch
14 AI Stocks to Stay Away From
<p><a rel="nofollow" href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice & Trading Tips</a></p> <p>Whether in transportation, manufacturing or healthcare, don't touch any... 
Tags Stocks to Sell T BSX
From InvestorPlace
Cassava Stock Pops Again; Can It Take On Biogen In Alzheimer's Drugs?
Cassava Sciences is part of a shift in Alzheimer's treatment, an analyst said Tuesday as he boosted his price target on SAVA stock. Shares of the leading Alzheimer's stock popped again. 
From Investor's Business Daily
Notable Insider Buys: Biotech IPOs, Curiositystream, Greenbrier And More
Conventional wisdom says that insiders and 10% owners really only buy shares of a company for one reason, they believe the stock price will rise and they want to profit from it. So insider buying can... 
Tags Pharma/Biotech Services Financial
From Blogs - TalkMarkets
The Past Week's Notable Insider Buys: Biotech IPOs, Curiositystream, Greenbrier And More
Insider buying can be an encouraging signal for potential investors, especially when markets face uncertainty. Some insiders have ... 
Tags CuriosityStream TAP Landos Biopharma
From Benzinga
TE Connectivity Takes Over #161 Spot From Biogen
In the latest look at the underlying components of the S&P 500 ordered by largest market capitalization, TE Connectivity Ltd (TEL) has taken over the #161 spot from Biogen Inc (BIIB), according to The... 
Tags Stocks
From Market News Video
Looking For Biotech Stocks To Buy Now? 4 Names To Know
Tags Market News
From StockMarket.com
Is the FDA Delay Actually Good News for Biogen's Alzheimer's Drug?
The lack of a quick rejection could be a good sign for the drug's prospects. 
Tags BIIB Market News ESALY
From Motley Fool
Why Is Everyone Talking About Biogen Stock?
A make it or break it regulatory decision is on the horizon. 
Tags Market News SAGE BIIB
From Motley Fool
Why Alkermes' Q4 Results Were Better Than They Might Seem
The biotech posted a big year-over-year sales decline. But there was a good reason for it. 
Tags Market News ALKS BIIB
From Motley Fool
ACIU Stock: Why AC Immune Shares Are Rocketing Higher Today
<p><a rel="nofollow" href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice & Trading Tips</a></p> <p>Swiss biopharma AC Immune has released positive updates this week on both... 
Tags BIIB Market News ACIU
From InvestorPlace
Alzheimer's Vaccine Prods AC Immune Stock To A Seven-Month High
Biotech company AC Immune said Thursday its Alzheimer's vaccine generated key antibodies in the brain, leading ACIU stock to pop. Shares hit a three-year high in premarket action. 
From Investor's Business Daily
Biogen (BIIB) Shares Cross Above 200 DMA
In trading on Wednesday, shares of Biogen Inc (BIIB) crossed above their 200 day moving average of $274.67, changing hands as high as $277.25 per share. Biogen Inc shares are currently trading up about... 
Tags Stocks
From Market News Video
Should You Sell Cassava Sciences Stock Now?
Can this company's Alzheimer's disease candidate deliver further gains ahead? 
Tags Market News BIIB SAVA
From Motley Fool
Correcting Barron's And Loving Lazard
After the football championship yesterday there was nothing for Wall Street to do except rise to new heights today. 
Tags Stocks / Equities
From Blogs - TalkMarkets
How Will Biotech ETFs React To These Q4 Earnings Releases?
Any positive news highlighting the progress of vaccine or antibody manufacturers is expected to create great returns for investors. Let’s take a look at some biotechnological earnings releases to see... 
Tags Pharma/Biotech ETFs Stocks / Equities
From Blogs - TalkMarkets
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.